280 related articles for article (PubMed ID: 32805422)
1. Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
Gendrot M; Duflot I; Boxberger M; Delandre O; Jardot P; Le Bideau M; Andreani J; Fonta I; Mosnier J; Rolland C; Hutter S; La Scola B; Pradines B
Int J Infect Dis; 2020 Oct; 99():437-440. PubMed ID: 32805422
[TBL] [Abstract][Full Text] [Related]
2. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Pryce J; Hine P
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation.
Gendrot M; Andreani J; Boxberger M; Jardot P; Fonta I; Le Bideau M; Duflot I; Mosnier J; Rolland C; Bogreau H; Hutter S; La Scola B; Pradines B
Travel Med Infect Dis; 2020; 37():101873. PubMed ID: 32916297
[TBL] [Abstract][Full Text] [Related]
4. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
5. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Blanshard A; Hine P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
[TBL] [Abstract][Full Text] [Related]
7. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
8. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W
ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
[TBL] [Abstract][Full Text] [Related]
10. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Marwa K; Kapesa A; Baraka V; Konje E; Kidenya B; Mukonzo J; Kamugisha E; Swedberg G
PLoS One; 2022; 17(3):e0264339. PubMed ID: 35271592
[TBL] [Abstract][Full Text] [Related]
12. Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
Henrich PP; O'Brien C; Sáenz FE; Cremers S; Kyle DE; Fidock DA
Antimicrob Agents Chemother; 2014; 58(1):183-95. PubMed ID: 24145526
[TBL] [Abstract][Full Text] [Related]
13. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
14. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
[TBL] [Abstract][Full Text] [Related]
15. Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Bukirwa H; Unnikrishnan B; Kramer CV; Sinclair D; Nair S; Tharyan P
Cochrane Database Syst Rev; 2014 Mar; (3):CD006404. PubMed ID: 24596021
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin for treating uncomplicated malaria.
van Eijk AM; Terlouw DJ
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD006688. PubMed ID: 21328286
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R
BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
Hutagalung R; Paiphun L; Ashley EA; McGready R; Brockman A; Thwai KL; Singhasivanon P; Jelinek T; White NJ; Nosten FH
Malar J; 2005 Sep; 4():46. PubMed ID: 16179089
[TBL] [Abstract][Full Text] [Related]
20. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.
Nair MS; Huang Y; Fidock DA; Polyak SJ; Wagoner J; Towler MJ; Weathers PJ
J Ethnopharmacol; 2021 Jun; 274():114016. PubMed ID: 33716085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
